Wegovy is also a GLP-one receptor agonist and incorporates semaglutide as its Lively ingredient. However, Wegovy is exclusively made for excess weight administration and is also FDA-permitted for use in people without diabetic issues. Limits of Use: The efficiency of SPRAVATO in protecting against suicide or in cutting down suicidal ideation or a